Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.101ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.101ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.101EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-20419.5China
B.1.1.101EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.101ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16984.7China
B.1.1.101ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.478EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.478EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.478ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.478ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.478EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.478EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.478ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.478ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.86EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.86EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.86ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.86ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.86EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.86EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.86ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.86ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.543EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.543EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.543ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.543ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.543EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.543EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.543ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.543ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.139EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.139EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.139ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.139ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.139EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.139EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.139ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.139ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.28EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.28ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.28ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.28EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.28EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GK.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GK.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used